

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of mast cell activation (GO:0033005) | 9.56033261 |
| 2 | regulation of tolerance induction (GO:0002643) | 9.36830631 |
| 3 | regulation of T cell cytokine production (GO:0002724) | 9.04732823 |
| 4 | cellular biogenic amine biosynthetic process (GO:0042401) | 8.38607166 |
| 5 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 8.03485537 |
| 6 | amine biosynthetic process (GO:0009309) | 7.93346405 |
| 7 | positive regulation of leukocyte degranulation (GO:0043302) | 7.70375921 |
| 8 | catechol-containing compound biosynthetic process (GO:0009713) | 7.47935977 |
| 9 | catecholamine biosynthetic process (GO:0042423) | 7.47935977 |
| 10 | regulation of mast cell activation involved in immune response (GO:0033006) | 7.32554198 |
| 11 | T cell apoptotic process (GO:0070231) | 7.01745949 |
| 12 | angiotensin maturation (GO:0002003) | 6.49421713 |
| 13 | regulation of mast cell activation (GO:0033003) | 6.06956145 |
| 14 | lymphocyte apoptotic process (GO:0070227) | 5.98276068 |
| 15 | regulation of mast cell degranulation (GO:0043304) | 5.94238629 |
| 16 | sequestering of actin monomers (GO:0042989) | 5.72658849 |
| 17 | lipoxygenase pathway (GO:0019372) | 5.69627283 |
| 18 | positive regulation of regulated secretory pathway (GO:1903307) | 5.47953558 |
| 19 | replication fork processing (GO:0031297) | 5.29315416 |
| 20 | leukocyte apoptotic process (GO:0071887) | 5.06195484 |
| 21 | endosome to pigment granule transport (GO:0043485) | 4.96181449 |
| 22 | endosome to melanosome transport (GO:0035646) | 4.96181449 |
| 23 | regulation of activated T cell proliferation (GO:0046006) | 4.72134734 |
| 24 | peroxisome fission (GO:0016559) | 4.62334643 |
| 25 | negative regulation of mast cell activation (GO:0033004) | 4.47778777 |
| 26 | thrombin receptor signaling pathway (GO:0070493) | 4.43846714 |
| 27 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.41031819 |
| 28 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.41031819 |
| 29 | centriole replication (GO:0007099) | 4.31454379 |
| 30 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.23559773 |
| 31 | phenol-containing compound biosynthetic process (GO:0046189) | 4.18111453 |
| 32 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.10983495 |
| 33 | interleukin-6-mediated signaling pathway (GO:0070102) | 4.08406337 |
| 34 | regulation of leukocyte degranulation (GO:0043300) | 4.07667157 |
| 35 | negative regulation of norepinephrine secretion (GO:0010700) | 4.07235711 |
| 36 | regulation of glucokinase activity (GO:0033131) | 4.07125063 |
| 37 | regulation of hexokinase activity (GO:1903299) | 4.07125063 |
| 38 | centrosome duplication (GO:0051298) | 4.03397517 |
| 39 | protein neddylation (GO:0045116) | 3.94003961 |
| 40 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.86667613 |
| 41 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.86667613 |
| 42 | adenosine receptor signaling pathway (GO:0001973) | 3.75959395 |
| 43 | tachykinin receptor signaling pathway (GO:0007217) | 3.74376681 |
| 44 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.70529449 |
| 45 | urate metabolic process (GO:0046415) | 3.66973089 |
| 46 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.65142087 |
| 47 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.64061284 |
| 48 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.61860107 |
| 49 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.59128405 |
| 50 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.45404595 |
| 51 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.45109175 |
| 52 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.40429213 |
| 53 | regulation of T cell mediated immunity (GO:0002709) | 3.35758946 |
| 54 | regulation of regulated secretory pathway (GO:1903305) | 3.34912267 |
| 55 | translesion synthesis (GO:0019985) | 3.33325852 |
| 56 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.31358354 |
| 57 | resolution of meiotic recombination intermediates (GO:0000712) | 3.31212830 |
| 58 | cytokine biosynthetic process (GO:0042089) | 3.27446440 |
| 59 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 3.24887798 |
| 60 | leukotriene biosynthetic process (GO:0019370) | 3.23896017 |
| 61 | positive regulation of DNA recombination (GO:0045911) | 3.22144295 |
| 62 | centriole assembly (GO:0098534) | 3.18375822 |
| 63 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.17599677 |
| 64 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.16667787 |
| 65 | regulation of meiosis I (GO:0060631) | 3.14732483 |
| 66 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.14684324 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.14432070 |
| 68 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.08776080 |
| 69 | regulation of chronic inflammatory response (GO:0002676) | 3.08561593 |
| 70 | cellular response to virus (GO:0098586) | 3.06678279 |
| 71 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 3.02776245 |
| 72 | cytokine secretion (GO:0050663) | 3.00699586 |
| 73 | negative regulation of catecholamine secretion (GO:0033604) | 2.95672812 |
| 74 | positive regulation of gastrulation (GO:2000543) | 2.93544316 |
| 75 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.93075443 |
| 76 | regulation of penile erection (GO:0060405) | 2.92948055 |
| 77 | catecholamine metabolic process (GO:0006584) | 2.89260266 |
| 78 | catechol-containing compound metabolic process (GO:0009712) | 2.89260266 |
| 79 | peptide hormone processing (GO:0016486) | 2.85197618 |
| 80 | regulation of cofactor metabolic process (GO:0051193) | 2.84442245 |
| 81 | regulation of coenzyme metabolic process (GO:0051196) | 2.84442245 |
| 82 | neutrophil activation (GO:0042119) | 2.84003209 |
| 83 | negative regulation of bone mineralization (GO:0030502) | 2.81155015 |
| 84 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.78046760 |
| 85 | neutrophil activation involved in immune response (GO:0002283) | 2.68842782 |
| 86 | phosphatidic acid biosynthetic process (GO:0006654) | 2.68666888 |
| 87 | phosphatidic acid metabolic process (GO:0046473) | 2.68666888 |
| 88 | metallo-sulfur cluster assembly (GO:0031163) | 2.65708843 |
| 89 | iron-sulfur cluster assembly (GO:0016226) | 2.65708843 |
| 90 | cytokine metabolic process (GO:0042107) | 2.64536238 |
| 91 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.62353227 |
| 92 | mRNA transcription (GO:0009299) | 2.61965862 |
| 93 | purinergic receptor signaling pathway (GO:0035587) | 2.56915639 |
| 94 | male meiosis (GO:0007140) | 2.54434748 |
| 95 | intra-S DNA damage checkpoint (GO:0031573) | 2.51796405 |
| 96 | protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205) | 2.49579126 |
| 97 | imidazole-containing compound metabolic process (GO:0052803) | 15.3797599 |
| 98 | regulation of T cell tolerance induction (GO:0002664) | 11.2692272 |
| 99 | positive regulation of mast cell degranulation (GO:0043306) | 10.8685761 |
| 100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 10.8685761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 5.61899959 |
| 2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.76766146 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.57341766 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.70780326 |
| 5 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.56530587 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.54759120 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.28350115 |
| 8 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.26569206 |
| 9 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.23064757 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.09659780 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08895612 |
| 12 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.08305057 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.05693793 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 13.3965718 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.99527670 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96510924 |
| 17 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.95644717 |
| 18 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.93507969 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.66036276 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64717402 |
| 21 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.64438484 |
| 22 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.62791805 |
| 23 | GATA1_19941826_ChIP-Seq_K562_Human | 1.54676548 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.48869327 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 1.42653882 |
| 26 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35669466 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35344931 |
| 28 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.31745184 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30661073 |
| 30 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30507565 |
| 31 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.30415700 |
| 32 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.24054997 |
| 33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23264113 |
| 34 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23186677 |
| 35 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21205476 |
| 36 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19711277 |
| 37 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.17429107 |
| 38 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.16895253 |
| 39 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15879979 |
| 40 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.15302453 |
| 41 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.14030003 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.13460411 |
| 43 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.09832873 |
| 44 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06667197 |
| 45 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.03532570 |
| 46 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01775831 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.99966443 |
| 48 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.99959567 |
| 49 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.98751635 |
| 50 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97623288 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96991533 |
| 52 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.96911727 |
| 53 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95620378 |
| 54 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94846780 |
| 55 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.92528857 |
| 56 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92165220 |
| 57 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92004063 |
| 58 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.91450472 |
| 59 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91055054 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90398150 |
| 61 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.89327251 |
| 62 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89065293 |
| 63 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89065293 |
| 64 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.88185878 |
| 65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.88030221 |
| 66 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.86423819 |
| 67 | SPI1_23127762_ChIP-Seq_K562_Human | 0.86239574 |
| 68 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.84927157 |
| 69 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.84824780 |
| 70 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84289152 |
| 71 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.84211681 |
| 72 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83459768 |
| 73 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.82988684 |
| 74 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.82431049 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81822702 |
| 76 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.80496198 |
| 77 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79665186 |
| 78 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.78480149 |
| 79 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.78274892 |
| 80 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.77956031 |
| 81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.76661908 |
| 82 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.76372991 |
| 83 | STAT3_23295773_ChIP-Seq_U87_Human | 0.74647902 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74525477 |
| 85 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.73035115 |
| 86 | MYB_26560356_Chip-Seq_TH2_Human | 0.72722925 |
| 87 | P300_19829295_ChIP-Seq_ESCs_Human | 0.71912558 |
| 88 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.71163964 |
| 89 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.71163964 |
| 90 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.70852657 |
| 91 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.69558239 |
| 92 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.68861436 |
| 93 | NCOR_22424771_ChIP-Seq_293T_Human | 0.68851973 |
| 94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.68046553 |
| 95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.67751930 |
| 96 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67315020 |
| 97 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.67205088 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 0.66905355 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.66844742 |
| 100 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.66570869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002735_abnormal_chemical_nociception | 7.98708024 |
| 2 | MP0005464_abnormal_platelet_physiology | 4.90243986 |
| 3 | MP0005171_absent_coat_pigmentation | 3.76046248 |
| 4 | MP0002733_abnormal_thermal_nociception | 3.13997707 |
| 5 | MP0002734_abnormal_mechanical_nocicepti | 2.97905527 |
| 6 | MP0008961_abnormal_basal_metabolism | 2.95710910 |
| 7 | MP0001873_stomach_inflammation | 2.87444824 |
| 8 | MP0003183_abnormal_peptide_metabolism | 2.85456965 |
| 9 | MP0002971_abnormal_brown_adipose | 2.69540180 |
| 10 | MP0000372_irregular_coat_pigmentation | 2.58663057 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.56946721 |
| 12 | MP0009115_abnormal_fat_cell | 2.44644480 |
| 13 | MP0002736_abnormal_nociception_after | 2.39075762 |
| 14 | MP0005448_abnormal_energy_balance | 2.35802085 |
| 15 | MP0003638_abnormal_response/metabolism_ | 2.35607271 |
| 16 | MP0005075_abnormal_melanosome_morpholog | 2.33989040 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 2.33654743 |
| 18 | MP0008872_abnormal_physiological_respon | 2.23138529 |
| 19 | MP0005503_abnormal_tendon_morphology | 2.14337236 |
| 20 | MP0005083_abnormal_biliary_tract | 2.11512929 |
| 21 | MP0001970_abnormal_pain_threshold | 2.05387286 |
| 22 | MP0008058_abnormal_DNA_repair | 1.98071071 |
| 23 | MP0008004_abnormal_stomach_pH | 1.93330875 |
| 24 | MP0003283_abnormal_digestive_organ | 1.89388813 |
| 25 | MP0003787_abnormal_imprinting | 1.81103542 |
| 26 | MP0006276_abnormal_autonomic_nervous | 1.79697249 |
| 27 | MP0009765_abnormal_xenobiotic_induced | 1.79147491 |
| 28 | MP0001348_abnormal_lacrimal_gland | 1.72485714 |
| 29 | MP0001529_abnormal_vocalization | 1.56834409 |
| 30 | MP0003136_yellow_coat_color | 1.53879710 |
| 31 | MP0001968_abnormal_touch/_nociception | 1.51960339 |
| 32 | MP0009697_abnormal_copulation | 1.47300324 |
| 33 | MP0002970_abnormal_white_adipose | 1.44893778 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.41230113 |
| 35 | MP0005334_abnormal_fat_pad | 1.39708078 |
| 36 | MP0009840_abnormal_foam_cell | 1.37007960 |
| 37 | MP0005410_abnormal_fertilization | 1.27702593 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.26160179 |
| 39 | MP0008877_abnormal_DNA_methylation | 1.25406805 |
| 40 | MP0000230_abnormal_systemic_arterial | 1.23057016 |
| 41 | MP0002572_abnormal_emotion/affect_behav | 1.21986677 |
| 42 | MP0005394_taste/olfaction_phenotype | 1.19200815 |
| 43 | MP0005499_abnormal_olfactory_system | 1.19200815 |
| 44 | MP0001835_abnormal_antigen_presentation | 1.13108783 |
| 45 | MP0001790_abnormal_immune_system | 1.11618096 |
| 46 | MP0005387_immune_system_phenotype | 1.11618096 |
| 47 | MP0005174_abnormal_tail_pigmentation | 1.09621135 |
| 48 | MP0003718_maternal_effect | 1.09472064 |
| 49 | MP0003950_abnormal_plasma_membrane | 1.08216257 |
| 50 | MP0001984_abnormal_olfaction | 1.06935938 |
| 51 | MP0006082_CNS_inflammation | 1.05405432 |
| 52 | MP0008995_early_reproductive_senescence | 0.99412465 |
| 53 | MP0001663_abnormal_digestive_system | 0.98156686 |
| 54 | MP0010329_abnormal_lipoprotein_level | 0.96894160 |
| 55 | MP0000733_abnormal_muscle_development | 0.96682707 |
| 56 | MP0009763_increased_sensitivity_to | 0.96464166 |
| 57 | MP0004130_abnormal_muscle_cell | 0.93128607 |
| 58 | MP0002398_abnormal_bone_marrow | 0.92767249 |
| 59 | MP0005647_abnormal_sex_gland | 0.91445864 |
| 60 | MP0002405_respiratory_system_inflammati | 0.90344965 |
| 61 | MP0002429_abnormal_blood_cell | 0.86540623 |
| 62 | MP0003698_abnormal_male_reproductive | 0.85814987 |
| 63 | MP0003724_increased_susceptibility_to | 0.84735246 |
| 64 | MP0010094_abnormal_chromosome_stability | 0.84568258 |
| 65 | MP0003195_calcinosis | 0.83437962 |
| 66 | MP0002722_abnormal_immune_system | 0.82449924 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 0.81576061 |
| 68 | MP0000716_abnormal_immune_system | 0.80084779 |
| 69 | MP0002127_abnormal_cardiovascular_syste | 0.79413014 |
| 70 | MP0001800_abnormal_humoral_immune | 0.79307723 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.78638485 |
| 72 | MP0005076_abnormal_cell_differentiation | 0.74114792 |
| 73 | MP0008789_abnormal_olfactory_epithelium | 0.73480306 |
| 74 | MP0002234_abnormal_pharynx_morphology | 0.71545665 |
| 75 | MP0005332_abnormal_amino_acid | 0.69812003 |
| 76 | MP0002118_abnormal_lipid_homeostasis | 0.68840141 |
| 77 | MP0006036_abnormal_mitochondrial_physio | 0.67769786 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.67013119 |
| 79 | MP0003953_abnormal_hormone_level | 0.66840571 |
| 80 | MP0005666_abnormal_adipose_tissue | 0.65921915 |
| 81 | MP0002272_abnormal_nervous_system | 0.65272066 |
| 82 | MP0001819_abnormal_immune_cell | 0.65178180 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64730410 |
| 84 | MP0002420_abnormal_adaptive_immunity | 0.64243493 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 0.63677270 |
| 86 | MP0002723_abnormal_immune_serum | 0.62476853 |
| 87 | MP0002078_abnormal_glucose_homeostasis | 0.61035237 |
| 88 | MP0003303_peritoneal_inflammation | 0.60686871 |
| 89 | MP0002822_catalepsy | 0.60571297 |
| 90 | MP0000249_abnormal_blood_vessel | 0.60194340 |
| 91 | MP0002210_abnormal_sex_determination | 0.59848336 |
| 92 | MP0005452_abnormal_adipose_tissue | 0.59119655 |
| 93 | MP0002452_abnormal_antigen_presenting | 0.58918628 |
| 94 | MP0000343_altered_response_to | 0.56531689 |
| 95 | MP0005310_abnormal_salivary_gland | 0.56481932 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.56247650 |
| 97 | MP0001929_abnormal_gametogenesis | 0.55081816 |
| 98 | MP0000689_abnormal_spleen_morphology | 0.54851744 |
| 99 | MP0002102_abnormal_ear_morphology | 0.54656972 |
| 100 | MP0005671_abnormal_response_to | 0.52491888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Male infertility (HP:0003251) | 8.99697141 |
| 2 | Failure to thrive in infancy (HP:0001531) | 7.52952986 |
| 3 | Prolonged bleeding time (HP:0003010) | 6.04713146 |
| 4 | Petechiae (HP:0000967) | 4.99979488 |
| 5 | Menorrhagia (HP:0000132) | 4.98145746 |
| 6 | Increased mean platelet volume (HP:0011877) | 4.75773682 |
| 7 | Abnormal platelet volume (HP:0011876) | 4.35411403 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.14657775 |
| 9 | Purpura (HP:0000979) | 4.07210688 |
| 10 | Rough bone trabeculation (HP:0100670) | 3.94480879 |
| 11 | Epistaxis (HP:0000421) | 3.90242481 |
| 12 | Premature graying of hair (HP:0002216) | 3.83779564 |
| 13 | Autoimmune thrombocytopenia (HP:0001973) | 3.80498488 |
| 14 | Rhinitis (HP:0012384) | 3.65707823 |
| 15 | Recurrent corneal erosions (HP:0000495) | 3.65522317 |
| 16 | Orthostatic hypotension (HP:0001278) | 3.64918111 |
| 17 | Renal Fanconi syndrome (HP:0001994) | 3.57612148 |
| 18 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.56434179 |
| 19 | Recurrent sinusitis (HP:0011108) | 3.45356152 |
| 20 | Gingival bleeding (HP:0000225) | 3.44051030 |
| 21 | Episodic fever (HP:0001954) | 3.31308348 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.30599745 |
| 23 | Papilledema (HP:0001085) | 3.30585866 |
| 24 | Hypophosphatemic rickets (HP:0004912) | 3.26306295 |
| 25 | Generalized aminoaciduria (HP:0002909) | 3.15954493 |
| 26 | Impaired proprioception (HP:0010831) | 2.97816270 |
| 27 | Infertility (HP:0000789) | 2.93808561 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 2.92365978 |
| 29 | Arthropathy (HP:0003040) | 2.90174326 |
| 30 | Alveolar cell carcinoma (HP:0006519) | 2.87243801 |
| 31 | Autoimmune hemolytic anemia (HP:0001890) | 2.83933406 |
| 32 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.75491968 |
| 33 | Impaired platelet aggregation (HP:0003540) | 2.75422006 |
| 34 | Abnormal platelet function (HP:0011869) | 2.75422006 |
| 35 | Abnormal trabecular bone morphology (HP:0100671) | 2.73894374 |
| 36 | Intrahepatic cholestasis (HP:0001406) | 2.65643506 |
| 37 | Ventricular fibrillation (HP:0001663) | 2.61051828 |
| 38 | Dysautonomia (HP:0002459) | 2.50746885 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.50002546 |
| 40 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.48741475 |
| 41 | Xanthomatosis (HP:0000991) | 2.48666765 |
| 42 | Abnormal drinking behavior (HP:0030082) | 2.42437929 |
| 43 | Polydipsia (HP:0001959) | 2.42437929 |
| 44 | Acute hepatic failure (HP:0006554) | 2.37496393 |
| 45 | Abnormality of the renal collecting system (HP:0004742) | 2.36565117 |
| 46 | Duplicated collecting system (HP:0000081) | 2.31879373 |
| 47 | Aplastic anemia (HP:0001915) | 2.31678457 |
| 48 | Cellular immunodeficiency (HP:0005374) | 2.30197820 |
| 49 | IgG deficiency (HP:0004315) | 2.29836892 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29623929 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29623929 |
| 52 | Panhypogammaglobulinemia (HP:0003139) | 2.29186379 |
| 53 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.22059898 |
| 54 | Bone marrow hypocellularity (HP:0005528) | 2.20698240 |
| 55 | Conjunctival telangiectasia (HP:0000524) | 2.18833011 |
| 56 | Bruising susceptibility (HP:0000978) | 2.17912903 |
| 57 | Alacrima (HP:0000522) | 2.17078447 |
| 58 | Stomatitis (HP:0010280) | 2.14462291 |
| 59 | Neurodegeneration (HP:0002180) | 2.13530399 |
| 60 | Cutaneous melanoma (HP:0012056) | 2.12648357 |
| 61 | Albinism (HP:0001022) | 2.10137269 |
| 62 | Tetraparesis (HP:0002273) | 2.09297332 |
| 63 | Abnormality of renal resorption (HP:0011038) | 2.09128386 |
| 64 | Spastic diplegia (HP:0001264) | 2.06369622 |
| 65 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.03392808 |
| 66 | Conjugated hyperbilirubinemia (HP:0002908) | 2.00582068 |
| 67 | Recurrent viral infections (HP:0004429) | 1.99674697 |
| 68 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.99156717 |
| 69 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.95730831 |
| 70 | Generalized hyperpigmentation (HP:0007440) | 1.95071476 |
| 71 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93780832 |
| 72 | Dyschromatopsia (HP:0007641) | 1.91566096 |
| 73 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91027101 |
| 74 | Poor eye contact (HP:0000817) | 1.90995808 |
| 75 | Basal ganglia calcification (HP:0002135) | 1.90570790 |
| 76 | Abolished electroretinogram (ERG) (HP:0000550) | 1.88424953 |
| 77 | Spastic gait (HP:0002064) | 1.88314073 |
| 78 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.87872722 |
| 79 | Hyponatremia (HP:0002902) | 1.87504643 |
| 80 | Spontaneous abortion (HP:0005268) | 1.86119303 |
| 81 | Glycosuria (HP:0003076) | 1.82707033 |
| 82 | Abnormality of urine glucose concentration (HP:0011016) | 1.82707033 |
| 83 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.82469913 |
| 84 | Decreased central vision (HP:0007663) | 1.81744174 |
| 85 | Abnormality of macrophages (HP:0004311) | 1.79407829 |
| 86 | Abnormality of T cells (HP:0002843) | 1.77584678 |
| 87 | Abnormality of the basal ganglia (HP:0002134) | 1.76618367 |
| 88 | Polyphagia (HP:0002591) | 1.75647520 |
| 89 | Aseptic necrosis (HP:0010885) | 1.72962657 |
| 90 | Poikilocytosis (HP:0004447) | 1.72201650 |
| 91 | Acanthocytosis (HP:0001927) | 1.70718326 |
| 92 | J-shaped sella turcica (HP:0002680) | 1.64510928 |
| 93 | Abnormality of sodium homeostasis (HP:0010931) | 1.63497894 |
| 94 | Decreased lacrimation (HP:0000633) | 1.62265879 |
| 95 | Congenital sensorineural hearing impairment (HP:0008527) | 1.60179887 |
| 96 | Abnormality of the hepatic vasculature (HP:0006707) | 1.58864682 |
| 97 | Bronchiectasis (HP:0002110) | 1.58810492 |
| 98 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.58032926 |
| 99 | Polyuria (HP:0000103) | 1.57647565 |
| 100 | Delusions (HP:0000746) | 1.56017130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 3.95579934 |
| 2 | FER | 2.63504454 |
| 3 | TAOK1 | 2.53950752 |
| 4 | GRK6 | 2.23769507 |
| 5 | PNCK | 2.10383453 |
| 6 | TRIM28 | 11.9733076 |
| 7 | MARK3 | 1.69557890 |
| 8 | DAPK2 | 1.65818619 |
| 9 | MATK | 1.62030820 |
| 10 | CSF1R | 1.59280040 |
| 11 | MST4 | 1.54979324 |
| 12 | BCKDK | 1.46243734 |
| 13 | IRAK3 | 1.45632073 |
| 14 | PDK2 | 1.39380065 |
| 15 | BMX | 1.32347545 |
| 16 | PRKD2 | 1.31163295 |
| 17 | PKN1 | 1.24797324 |
| 18 | GRK5 | 1.22152293 |
| 19 | MAPK13 | 1.19780576 |
| 20 | FRK | 1.19029711 |
| 21 | MYLK | 1.10720964 |
| 22 | SIK3 | 1.03738867 |
| 23 | BTK | 0.99863977 |
| 24 | TEC | 0.95896367 |
| 25 | FES | 0.94714172 |
| 26 | ADRBK2 | 0.94229068 |
| 27 | SYK | 0.93308770 |
| 28 | BMPR2 | 0.92684546 |
| 29 | TAOK2 | 0.89780989 |
| 30 | PTK2B | 0.85586562 |
| 31 | SIK2 | 0.85116173 |
| 32 | GRK7 | 0.84400505 |
| 33 | GRK1 | 0.82013355 |
| 34 | LYN | 0.81263150 |
| 35 | MARK2 | 0.81078728 |
| 36 | PIK3CG | 0.79384291 |
| 37 | TNK2 | 0.78576885 |
| 38 | ZAP70 | 0.76353054 |
| 39 | CAMKK2 | 0.74786437 |
| 40 | PAK1 | 0.69000497 |
| 41 | RIPK4 | 0.67753897 |
| 42 | IKBKE | 0.65965579 |
| 43 | CAMK1G | 0.65673885 |
| 44 | ADRBK1 | 0.65356100 |
| 45 | NTRK3 | 0.65025692 |
| 46 | DYRK1B | 0.57987273 |
| 47 | FGR | 0.57277363 |
| 48 | IRAK4 | 0.57141162 |
| 49 | EPHA4 | 0.56815304 |
| 50 | EIF2AK1 | 0.53924899 |
| 51 | PRKCI | 0.53865398 |
| 52 | GSK3A | 0.52824837 |
| 53 | ERBB2 | 0.52728990 |
| 54 | NTRK1 | 0.51104116 |
| 55 | STK38 | 0.50772927 |
| 56 | MAP4K1 | 0.49692487 |
| 57 | WNK4 | 0.49550409 |
| 58 | PIM1 | 0.49467013 |
| 59 | ERBB3 | 0.48334004 |
| 60 | HIPK2 | 0.47592869 |
| 61 | CAMK2G | 0.46487820 |
| 62 | CAMK2B | 0.45562271 |
| 63 | DAPK1 | 0.45320528 |
| 64 | IKBKB | 0.45230164 |
| 65 | CAMK2D | 0.42735957 |
| 66 | TESK2 | 0.42269862 |
| 67 | PHKG1 | 0.41666022 |
| 68 | PHKG2 | 0.41666022 |
| 69 | STK3 | 0.41336948 |
| 70 | INSR | 0.40308375 |
| 71 | MAPK10 | 0.39584085 |
| 72 | PRKCE | 0.38967154 |
| 73 | STK16 | 0.36906327 |
| 74 | MAPKAPK3 | 0.36794456 |
| 75 | PDK1 | 0.36227780 |
| 76 | PRKACG | 0.35913274 |
| 77 | STK39 | 0.34976004 |
| 78 | DAPK3 | 0.34873107 |
| 79 | TAOK3 | 0.34782166 |
| 80 | HCK | 0.34257403 |
| 81 | PLK2 | 0.34114464 |
| 82 | MARK1 | 0.33090428 |
| 83 | PRKACA | 0.32850703 |
| 84 | CHUK | 0.32783383 |
| 85 | MAP2K7 | 0.32170141 |
| 86 | PRPF4B | 0.31984042 |
| 87 | PRKCZ | 0.31928015 |
| 88 | ILK | 0.31538138 |
| 89 | BRSK2 | 0.31488830 |
| 90 | CAMK2A | 0.30953780 |
| 91 | TGFBR2 | 0.30269914 |
| 92 | OBSCN | 0.29166824 |
| 93 | CSK | 0.28290039 |
| 94 | PRKCA | 0.27950615 |
| 95 | BLK | 0.27587568 |
| 96 | WNK3 | 0.27268216 |
| 97 | TLK1 | 0.26819577 |
| 98 | JAK2 | 0.26794850 |
| 99 | LCK | 0.26540384 |
| 100 | TBK1 | 0.25573361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Histidine metabolism_Homo sapiens_hsa00340 | 6.96922268 |
| 2 | Asthma_Homo sapiens_hsa05310 | 5.48789557 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 5.41093681 |
| 4 | Platelet activation_Homo sapiens_hsa04611 | 2.58623144 |
| 5 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.41802024 |
| 6 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.37307526 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.24553651 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.22815780 |
| 9 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.01320422 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 1.96972019 |
| 11 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.83429551 |
| 12 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.76775148 |
| 13 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.73782497 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72357675 |
| 15 | Olfactory transduction_Homo sapiens_hsa04740 | 1.68153314 |
| 16 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.54364057 |
| 17 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.53823996 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.48841472 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.39231146 |
| 20 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.34292511 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29333100 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25263372 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.23559075 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.18143192 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.13832149 |
| 26 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01126927 |
| 27 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99707728 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98843241 |
| 29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.97916959 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.95616825 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 0.94579782 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90854579 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 0.90236880 |
| 34 | Phototransduction_Homo sapiens_hsa04744 | 0.89646800 |
| 35 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89183312 |
| 36 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.86309771 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 0.81161067 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81037580 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77078870 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 0.76960172 |
| 41 | Mismatch repair_Homo sapiens_hsa03430 | 0.75791469 |
| 42 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.75653524 |
| 43 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.73652465 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 0.72096070 |
| 45 | Gap junction_Homo sapiens_hsa04540 | 0.71577450 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70418421 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69868958 |
| 48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69431741 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68198351 |
| 50 | Taste transduction_Homo sapiens_hsa04742 | 0.67299045 |
| 51 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66567369 |
| 52 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65914544 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.64888245 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64744833 |
| 55 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64468891 |
| 56 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.63732080 |
| 57 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.63162493 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.61371034 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60146529 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.59853684 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58908517 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58748940 |
| 63 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.57886550 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56835459 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54728019 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54481556 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.53566848 |
| 68 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52349050 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52278606 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.51224701 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48249948 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.45870301 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42159720 |
| 74 | Alcoholism_Homo sapiens_hsa05034 | 0.41283308 |
| 75 | GABAergic synapse_Homo sapiens_hsa04727 | 0.39504513 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38600143 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37121074 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.35468296 |
| 79 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.33987542 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32984984 |
| 81 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.32068837 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31869151 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31542404 |
| 84 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31496528 |
| 85 | Insulin secretion_Homo sapiens_hsa04911 | 0.28793509 |
| 86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28753822 |
| 87 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.28273544 |
| 88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.25860130 |
| 89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.24621845 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.24219920 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.22713473 |
| 92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.22517564 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22380172 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21406201 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20763692 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.20628364 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20282486 |
| 98 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.19639783 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.18801033 |
| 100 | Allograft rejection_Homo sapiens_hsa05330 | 0.18493869 |

